ECR 2021: Ziehm Imaging presents powerful clinical packages for cardio- vascular interventions based on Ziehm Vision RFD Hybrid Edition

At this year’s virtual ECR congress, Ziehm Imaging showcases its leading portfolio of mobile C-arms and advanced imaging solutions. Highlights on display include two powerful clinical packages for cardio and vascular interventions based on the fully motorized Ziehm Vision RFD Hybrid Edition1, that provide clinical users with state-of-the-art imaging support and further workflow integration. The Read more about ECR 2021: Ziehm Imaging presents powerful clinical packages for cardio- vascular interventions based on Ziehm Vision RFD Hybrid Edition[…]

Global Orthopedic Devices Market is all set to reach US$ 59,688.8 Mn by 2025 from US$ 44,034.9 Mn in 2020

Fairfield Market Research highlights that the global orthopedic devices market is expected to witness a CAGR of 6.3% during the forecast years of 2020 and 2025. As the economy and patient sentiment limp back to normalcy, the research report estimates that the global market will be worth US$59,688.8 Mn by the end of 2025. All Read more about Global Orthopedic Devices Market is all set to reach US$ 59,688.8 Mn by 2025 from US$ 44,034.9 Mn in 2020[…]

Thanks to VSY Biotechnology, ophthalmologist will have more comfortable surgery experience and patients will have more enhanced vision

VSY Biotechnology provides the best vision to people worldwide and supplies the best technology to ophthalmologists. The company’s Pre-loaded IOL System Patent has been granted by the Japan Patent Office. VSY Biotechnology’s innovations are indeed for the comfort of everyone in the world. VSY Biotechnology GmbH, an innovation-driven company with its progressive R&D activities in Read more about Thanks to VSY Biotechnology, ophthalmologist will have more comfortable surgery experience and patients will have more enhanced vision[…]

Immunic, Inc. Reports Year End 2020 Financial Results and Highlights Recent Activity

Phase 3 Program of IMU-838 in Relapsing-Remitting Multiple Sclerosis Expected to Begin in the Second Half of 2021  Reported Positive Top-Line Data From Investigator-Sponsored Phase 2 Proof-of-Concept Clinical Trial of IMU-838 in Primary Sclerosing Cholangitis  Announced Main Analysis of Phase 2 CALVID-1 Trial of IMU-838 Showing Evidence of Clinical Activity in Patients with Moderate COVID-19  Read more about Immunic, Inc. Reports Year End 2020 Financial Results and Highlights Recent Activity[…]

Osnabrück Hospital Relies on Sharepoint Technology for Document Management

Around 2,500 employees and approx. 100,000 patients per year ensure a very high volume of data at Osnabrück Hospital. Data integrity and availability are particularly important in the day-to-day running of the hospital, as are short reaction times to changes in document control requirements. The software used so far could no longer do this satisfactorily Read more about Osnabrück Hospital Relies on Sharepoint Technology for Document Management[…]

Neues aus der Forschung

Wissenschaftlerinnen und Wissenschaftler des Universitätsklinikums Hamburg-Eppendorf (UKE) veröffentlichen neueste Erkenntnisse aus klinischer und Grundlagenforschung. Hier einige Hinweise auf aktuelle Publikationen und Forschungsprojekte. Publikation: Endorphine sind nicht verantwortlich für das Runner’s high Wissenschaftlerinnen und Wissenschaftler des Universitätsklinikums Hamburg-Eppendorf (UKE) konnten in einer Studie zeigen, dass Endorphine keine Rolle beim sogenannten Runner’s high spielen. Unter einem Runner’s Read more about Neues aus der Forschung[…]

Swiss-based medtech startup EBAMed appoints Marina Izzo as CEO

EBAMed SA, developer of medical technologies to transform the treatment of cardiac arrhythmias, has appointed experienced specialist Marina Izzo as Chief Executive Officer (CEO). Mrs. Izzo will set the vision for EBAMed’s technology and lead the effort for the next financing round, planned for 2022. Former CEO and co-founder, Adriano Garonna has transitioned to Chief Read more about Swiss-based medtech startup EBAMed appoints Marina Izzo as CEO[…]

Böllinghaus Steel donates 55.000 Euro to hospital in Leiria amid Covid-19 pandemic

Böllinghaus Steel has made a significant donation of 55.000 € to the Centro Hospitalar in Leiria. The donation will be used to support the hospital, its health care workers and patients affected by the COVID-19 pandemic through the purchase of critical equipment and supplies for the fight against the virus. “Our company has a strong Read more about Böllinghaus Steel donates 55.000 Euro to hospital in Leiria amid Covid-19 pandemic[…]

Eckert & Ziegler to Start Development of Radioisotope Production Facility in Jintan, PR China

Eckert & Ziegler (ISIN DE0005659700), a global specialist for radioactive medical and industrial applications based in Berlin, Germany, has signed an investment agreement with the Administrative Committee of Jiangsu Jintan Economic Development Zone (PR China) for the acquisition and commercial development of 13.300 square meters of industrial-use land. Provided that Eckert & Ziegler successfully completes Read more about Eckert & Ziegler to Start Development of Radioisotope Production Facility in Jintan, PR China[…]

Study: significantly less skin cancer diagnosed in 2020

The number of diagnosed cases of skin cancer was significantly reduced in 2020 compared to 2019, according to a recent article published in the “Journal of the American Academy of Dermatology”* by dermatologists from several American university hospitals. Dermatological societies observe this trend also in Europe and warn about the risks of a late diagnosis. Read more about Study: significantly less skin cancer diagnosed in 2020[…]